
Cheap creatine shows promise in boosting cancer immunotherapy
UCLA researchers found creatine, a cheap sports supplement, can energize dendritic cells and enhance killer T-cell activity, potentially boosting cancer immunotherapy. In melanoma mouse models, daily creatine slowed tumor growth and increased immune cell activity within tumours, suggesting creatine could support immune-based cancer therapies, including dendritic-cell vaccines. However, findings are preclinical and not dietary or medical recommendations; patients should consult physicians before using supplements during cancer treatment.












